Mitogenic growth signalling, DNA replication licensing, and survival are linked in prostate cancer

British Journal of Cancer

Volumn 96, Issue 9, 2007, Pages 1384-1393

  Dudderidge, T J ^a   McCracken, S R ^b   Loddo, M ^a   Fanshawe, T R ^c   Kelly, J D ^d   Neal, D E ^d   Leung, H Y ^b   Williams, G H ^a,e   Stoeber, K ^a,e  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

DNA replication licensing; Geminin; Mcm2; MEK5 ERK5; Prognosis; Prostate cancer

Indexed keywords

BIOLOGICAL MARKER; ECDYSONE; GEMININ; KI 67 ANTIGEN; MINICHROMOSOME MAINTENANCE PROTEIN 2; MITOGEN ACTIVATED PROTEIN KINASE 7; MUTANT PROTEIN;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CANCER CELL; CANCER GROWTH; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; DNA REPLICATION; ENZYME ACTIVATION; GENE DUPLICATION; GENE EXPRESSION SYSTEM; GENOME; GLEASON SCORE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MITOGENESIS; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; UNIVARIATE ANALYSIS;

CELL DIVISION; DNA REPLICATION; DNA, NEOPLASM; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MALE; PLASMIDS; PROSTATIC NEOPLASMS; SIGNAL TRANSDUCTION; SURVIVAL ANALYSIS;

EID: 34247627509     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6603718     Document Type: Article

References (43)

1. Abe J, Kusuhara M, Ulevitch RJ, Berk BC, Lee JD (1996) Big mitogen-activated protein kinase 1 (BMK1) is a redox-sensitive kinase. J Biol Chem 271: 16586-16590
2. Barsyte-Lovejoy D, Galanis A, Sharrocks AD (2002) Specificity determinants in MAPK signaling to transcription factors. J Biol Chem 277: 9896-9903
3. Blow JJ, Dutta A (2005) Preventing re-replication of chromosomal DNA. Nat Rev Mol Cell Biol 6: 476-486
4. Blow JJ, Hodgson B (2002) Replication licensing - defining the proliferative state? Trends Cell Biol 12: 72-78
5. Bouras T, Southey MC, Venter DJ (2001) Overexpression of the steroid receptor coactivator AIB1 in breast cancer. Cancer Res 61: 903-907
6. Cancer Research UK (2005) UK Prostate Cancer Mortality Statistics (http://info.cancerresearchuk.org/cancerstats/types/prostate/mortality)
7. Davies RJ, Freeman A, Morris LS, Bingham S, Dilworth S, Scott I, Laskey RA, Miller R, Coleman N (2002) Analysis of minichromosome maintenance proteins as a novel method for detection of colorectal cancer in stool. Lancet 359: 1917-1919
8. Dudderidge TJ, Stoeber K, Loddo M, Atkinson G, Fanshawe T, Griffiths DF, Williams GH (2005) Mcm2, Geminin, and KI67 define proliferative state and are prognostic markers in renal cell carcinoma. Clin Cancer Res 11: 2510-2517
9. English JM, Pearson G, Baer R, Cobb MH (1998) Identification of substrates and regulators of the mitogen-activated protein kinase ERK5 using chimeric protein kinases. J Biol Chem 273: 3854-3860
10. English JM, Vanderbilt CA, Xu S, Marcus S, Cobb MH (1995) Isolation of MEK5 and differential expression of alternatively spliced forms. J Biol Chem 270: 28897-28902
11. Eward KL, Obermann EC, Shreeram S, Loddo M, Fanshawe T, Williams C, Jung HI, Prevost AT, Blow JJ, Stoeber K, Williams GH (2004) DNA replication licensing in somatic and germ cells. J Cell Sci 117: 5875-5886
12. Faraggi D, Simon R (1996) A simulation study of cross-validation for selecting an optimal cutpoint in univariate survival analysis. Stat Med 15: 2203-2213
13. Gleason DF (1992) Histologic grading of prostate cancer: a perspective. Hum Pathol 23: 273-279
14. Gnanapragasam VJ, Robinson MC, Marsh C, Robson CN, Hamdy FC, Leung HY (2003) FGF8 isoform b expression in human prostate cancer. Br J Cancer 88: 1432-1438
15. Going JJ, Keith WN, Neilson L, Stoeber K, Stuart RC, Williams GH (2002) Aberrant expression of minichromosome maintenance proteins 2, 5 and Ki-67 in dysplastic squamous oesophageal epithelium and Barrett's mucosa. Gut 50: 373-377
16. Gonzalez MA, Pinder SE, Callagy G, Vowler SL, Morris LS, Bird K, Bell JA, Laskey RA, Coleman N (2003) Minichromosome maintenance protein 2 is a strong independent prognostic marker in breast cancer. J Clin Oncol 21: 4306-4313
17. Guttridge DC, Albanese C, Reuther JY, Pestell RG, Baldwin Jr AS (1999) NF-kappaB controls cell growth and differentiation through transcriptional regulation of cyclin D1. Mol Cell Biol 19: 5785-5799
18. Hinz M, Krappmann D, Eichten A, Heder A, Scheidereit C, Strauss M (1999) NF-kappaB function in growth control: regulation of cyclin D1 expression and G0/G1-to-S-phase transition. Mol Cell Biol 19: 2690-2698
19. Hrouda D, Kirby R (1998) Mechanisms of local invasion and metastasis in prostate cancer. In: Belldegrun A, Kirby R, Oliver T (eds) New Perspectives in Prostate Cancer pp 61-69. Isis Medical Media Ltd: Oxford
20. Kato Y, Kravchenko VV, Tapping RI, Han J, Ulevitch RJ, Lee JD (1997) BMK1/ERK5 regulates serum-induced early gene expression through transcription factor MEF2C. EMBO J 16: 7054-7066
21. Kato Y, Tapping RI, Huang S, Watson MH, Ulevitch RJ, Lee JD (1998) Bmk1/Erk5 is required for cell proliferation induced by epidermal growth factor. Nature 395: 713-716
22. Kingsbury SR, Loddo M, Fanshawe T, Obermann EC, Prevost AT, Stoeber K, Williams GH (2005) Repression of DNA replication licensing in quiescence is independent of geminin and may define the cell cycle state of progenitor cells. Exp Cell Res 309: 56-67
23. Korkolopoulou P, Givalos N, Saetta A, Goudopoulou A, Gakiopoulou H, Thymara I, Thomas-Tsagli E, Patsouris E (2005) Minichromosome maintenance proteins 2 and 5 expression in muscle-invasive urothelial cancer: a multivariate survival study including proliferation markers and cell cycle regulators. Hum Pathol 36: 899-907
24. Kruger S, Thorns C, Stocker W, Muller-Kunert E, Bohle A, Feller AC (2003) Prognostic value of MCM2 immunoreactivity in stage T1 transitional cell carcinoma of the bladder. Eur Urol 43: 138-145
25. Machida YJ, Hamlin JL, Dutta A (2005) Right place, right time, and only once: replication initiation in metazoans. Cell 123: 13-24
26. Mehta PB, Jenkins BL, McCarthy L, Thilak L, Robson CN, Neal DE, Leung HY (2003) MEK5 overexpression is associated with metastatic prostate cancer, and stimulates proliferation, MMP-9 expression and invasion. Oncogene 22: 1381-1389
27. Meng MV, Grossfeld GD, Williams GH, Dilworth S, Stoeber K, Mulley TW, Weinberg V, Carroll PR, Tlsty TD (2001) Minichromosome maintenance protein 2 expression in prostate: characterization and association with outcome after therapy for cancer. Clin Cancer Res 7: 2712-2718
28. Mody N, Leitch J, Armstrong C, Dixon J, Cohen P (2001) Effects of MAP kinase cascade inhibitors on the MKK5/ERK5 pathway. FEBS Lett 502: 21-24
29. Obermann EC, Eward KL, Dogan A, Paul EA, Loddo M, Munson P, Williams GH, Stoeber K (2005) DNA replication licensing in peripheral B-cell lymphoma. J Pathol 205: 318-328
30. Padmanabhan V, Callas P, Philips G, Trainer TD, Beatty BG (2004) DNA replication regulation protein Mcm7 as a marker of proliferation in prostate cancer. J Clin Pathol 57: 1057-1062
31. Pearson G, English JM, White MA, Cobb MH (2001) ERK5 and ERK2 cooperate to regulate NF-kappaB and cell transformation. J Biol Chem 276: 7927-7931
32. Ren B, Yu G, Tseng GC, Cieply K, Gavel T, Nelson J, Michalopoulos G, Yu YP, Luo JH (2006) MCM7 amplification and overexpression are associated with prostate cancer progression. Oncogene 25: 1090-1098
33. Shetty A, Loddo M, Fanshawe T, Prevost AT, Sainsbury R, Williams GH, Stoeber K (2005) DNA replication licensing and cell cycle kinetics of normal and neoplastic breast. Br J Cancer 93: 1295-1300
34. Stoeber K, Halsall I, Freeman A, Swinn R, Doble A, Morris L, Coleman N, Bullock N, Laskey RA, Hales CN, Williams GH (1999) Immunoassay for urothelial cancers that detects DNA replication protein Mcm5 in urine. Lancet 354: 1524-1525
35. Stoeber K, Swinn R, Prevost AT, de Clive-Lowe P, Halsall I, Dilworth SM, Marr J, Turner WH, Bullock N, Doble A, Hales CN, Williams GH (2002) Diagnosis of genito-urinary tract cancer by detection of minichromosome maintenance 5 protein in urine sediments. J Natl Cancer Inst 94: 1071-1079
36. Stoeber K, Tlsty TD, Happerfield L, Thomas GA, Romanov S, Bobrow L, Williams ED, Williams GH (2001) DNA replication licensing and human cell proliferation. J Cell Sci 114: 2027-2041
37. Terasawa K, Okazaki K, Nishida E (2003) Regulation of c-Fos and Fra-1 by the MEK5-ERK5 pathway. Genes Cells 8: 263-273
38. Wharton SB, Chan KK, Anderson JR, Stoeber K, Williams GH (2001) Replicative Mcm2 protein as a novel proliferation marker in oligodendrogliomas and its relationship to Ki67 labelling index, histological grade and prognosis. Neuropathol Appl Neurobiol 27: 305-313
39. Wharton SB, Hibberd S, Eward KL, Crimmins D, Jellinek DA, Levy D, Stoeber K, Williams GH (2004) DNA replication licensing and cell cycle kinetics of oligodendroglial tumours. Br J Cancer 91: 262-269
40. Williams G, Stoeber K (1999) Clinical applications of a novel mammalian cell-free DNA replication system. Br J Cancer 80(Suppl 1): 20-24
41. Williams GH, Romanowski P, Morris L, Madine M, Mills AD, Stoeber K, Marr J, Laskey RA, Coleman N (1998) Improved cervical smear assessment using antibodies against proteins that regulate DNA replication. Proc Natl Acad Sci USA 95: 14932-14937
42. Williams GH, Swinn R, Prevost AT, Clive-Lowe P, Halsall I, Going JJ, Hales CN, Stoeber K, Middleton SJ (2004) Diagnosis of oesophageal cancer by detection of minichromosome maintenance 5 protein in gastric aspirates. Br J Cancer 91: 714-719
43. Zhou G, Bao ZQ, Dixon JE (1995) Components of a new human protein kinase signal transduction pathway. J Biol Chem 270: 12665-12669